Nav: Home

Advancing methodology at BESSY II: Automated evaluation speeds up the search for new active substance

October 04, 2016

The macromolecular crystallography beamlines at the BESSY II X-ray source are specially designed to highly automated structural analyses of protein crystals. With up to now more than 2,000 solved structures of protein molecules, these beamlines are by far the most productive ones in Germany and are in vigorous demand by groups from either an academic and industrial research area.

Now teams from HZB and Philipps-Universität Marburg in Germany have automated the evaluation of data records as well. The newly developed expert system identifies small molecule fragments bound to proteins in the raw X-ray diffraction data. These fragments represent suitable starting points for the development of an active substance. Using a series of 364 samples, the collaborating partners demonstrated that the expert system works reliably and can speed up the search for a suitable active agents.

The search for new substances that are effective against a disease is like the first step in cracking a high-security lock: the active substance needs to fit into the target molecule like a key in a lock. The target molecule is in this case a protein, responsible for a specific function in an organism. The degree to which this function is accomplished can be influenced by active agents. Thus, an appropriate active substance can correct a function that has gone out of control and causes a disease. However, you first need to identify such an appropriate substance. And this search can be very tedious. Figuratively speaking, an infinite number of keys can be imagined, and it would take a huge amount of time to test them all. An efficient safecracker will not spend a lot of time checking such a large bunch of keys, instead he will study the pins of the lock, pin after pin, until he can set each pin correctly. A similar procedure, called fragment screening, became the conventional approach in structural biology. To discover a prototypal "blueprint", you assemble several individual fragments to a larger entity. To do so, you test hundreds of very small molecules (fragments) as to whether they bind to the target protein. A first lead structure for an active substance is then assembled from those fragments that bind.

High troughput and strong demand: the MX-Beamlines

A highly automated version of this procedure is already running at the BESSY II MX beamlines for three years and facilitates high throughput of samples. With over 2000 solved protein structures so far, the macromolecular crystallography beamlines at BESSY are by far the most productive ones in Germany. They are heavily overbooked with demands originating from academic as well as industrial research user groups.

New expert system evaluates raw data

Now a collaborative research project between the Philipps-Universität Marburg and HZB has succeeded in bringing this automation a step further. "We are able to work through hundreds of samples using fragment screening where manual evaluation is hardly feasible any longer", says Dr. Manfred Weiss, who heads the HZB MX team. In collaboration with Prof. Gerhard Klebe and his group at Marburg, the teams jointly developed an expert system as a computer program that incorporates the expertise of scientists. This expert system evaluates the raw X-ray crystallography data using an iterative process pipeline of evaluation routines and identifies those fragments that bind to the protein. The group headed by Klebe made the protein crystals available together with a library of different fragment molecules suitable for protein binding. In collaboration, the partners tested the newly developed expert system using crystals of a specific protein soaked in total with 364 fragments in aqueous solutions.

Automatic refinement identifies additional candidates

The expert system is also capable to automatically refine the X-ray structures. "Without this automated refinement procedure of the iterative expert system, a fair portion of the fragments would have remained undetected", explains Weiss. "For example, we had only identified about 50 candidates during the first evaluation, while by using the iterative adaptive procedure an additional 32 candidates could be discovered." The work shows that the new expert system allows a more reliable detection of fragments that can be considered as suitable starting points or promising molecular portions for the development of potent active agents. This can speed up the search for new drug molecules.
Note: The collaboration is funded by the German Federal Ministry of Education and Research (BMBF) as a collaborative research project "Research on Condensed Matter at Large Scale Infrastructures " (2016-2019). At the end of the project, all users of the macromolecular crystallography beamlines will also obtain access the fragment library for their protein research and can use the developed expert system.

To the publication: High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits, Structure, (2016) DOI: 10.1016/j.str.2016.06.010

Helmholtz-Zentrum Berlin für Materialien und Energie

Related Protein Articles:

Protein aggregation: Protein assemblies relevant not only for neurodegenerative disease
Amyloid fibrils play a crucial role in neurodegenerative illnesses. Scientists from Heinrich Heine University Düsseldorf (HHU) and Forschungszentrum Jülich have now been able to use cryo-electron microscopy (cryo-EM) to decode the spatial structure of the fibrils that are formed from PI3K SH3 domains - an important model system for research.
Old protein, new tricks: UMD connects a protein to antibody immunity for the first time
How can a protein be a major contributor in the development of birth defects, and also hold the potential to provide symptom relief from autoimmune diseases like lupus?
Infection-fighting protein also senses protein misfolding in non-infected cells
Researchers at the University of Toronto have uncovered an immune mechanism by which host cells combat bacterial infection, and at the same time found that a protein crucial to that process can sense and respond to misfolded proteins in all mammalian cells.
Quorn protein builds muscle better than milk protein
A study from the University of Exeter has found that mycoprotein, the protein-rich food source that is unique to Quorn products, stimulates post-exercise muscle building to a greater extent than milk protein.
More than a protein factory
Researchers from the Stowers Institute for Medical Research have discovered a new function of ribosomes in human cells that may show the protein-making particle's role in destroying healthy mRNAs, the messages that decode DNA into protein.
More Protein News and Protein Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...